Abstract:Introduction: Achieving an ideal Tc-99m labeled nitroimidazole hypoxia marker is still considered to be of great interest. Metronidazole xanthate (MNXT) ligand was synthesized and radiolabeled with Tc-99m-glucoheptonate (GH) to form the (TcO)-Tc-99m-MNXT complex, for the potential use as a novel probe for imaging tumor hypoxia. Methods: For labeling, (TcO)-Tc-99m-MNXT was prepared by ligand-exchange reaction with Tc-99m-GH. The radiochemical purity of the (TcO)-Tc-99m-MNXT complex was measured by thin layer chromatography (TLC) and high performance liquid chromatography (HPLC). The distribution coefficient and stability of the complex was investigated. The structure of the (TcO)-Tc-99m-MNXT complex was verified by preparation and characterization of the corresponding stable rhenium complex. The cellular uptake of the (TcO)-Tc-99m-MNXT complex was determined in murine sarcoma 5180 cell lines under hypoxic and aerobic conditions. The biodistribution and single photon emission computed tomography (SPECT) image studies of the (TcO)-Tc-99m-MNXT complex were performed in mice bearing S 180 tumor. Results: The radiochemical purity of the (TcO)-Tc-99m-MNXT complex was over 90%. It had good in vitro stability and its distribution coefficient indicated that it was a hydrophilic complex. When Tc-99m and Re complexes were coinjected in HPLC, both radioactivity (for Tc-99m complex) and UV detectors (for Re complex) showed nearly identical HPLC profiles, suggesting their structures are similar. The tumor cell experiment and the biodistribution in mice bearing S 180 tumor showed that the (TcO)-Tc-99m-MNXT complex had a good hypoxic selectivity and accumulated in the tumor with high uptake and good retention. Single photon emission computed tomography (SPE') image studies showed that the tumor detection was observable. Conclusions: (TcO)-Tc-99m-MNXT is prepared from a kit without the need for purification and shows high tumor uptake, tumor/blood and tumor/muscle ratios, suggesting that it would be a promising candidate for imaging tumor hypoxia. (C) 2015 Elsevier Inc. All rights reserved.

Synthesis,Radiolabeling and Biodistribution of ~(99)Tc~m-Bnao Ethylene Glycol Monoethyl Ether Derivate

Preliminary studies of 99mTc-BnAO and its analogues: synthesis, radiolabeling and in vitro cell uptake.

Preparation and Bioevaluation of a Novel 99Mtc-Labelled Propylene Amine Oxime (pnao) Containing Two 4-Methyl-2-nitroimidazole Groups As a Promising Tumor Hypoxia Imaging Agent

Preparation and bioevaluation of a novel 99m Tc-labelled propylene amine oxime (PnAO) containing two 4-methyl-2-nitroimidazole groups as a promising tumor hypoxia imaging agent

Improving Tumor/muscle and Tumor/blood Ratios of 99Mtc-Labeled Nitroimidazole Propylene Amine Oxime (pnao) Complexes with Ethylene Glycol Linkers.

Synthesis and Biological Evaluation of Novel 99Mtcn-Labeled Bisnitroimidazole Complexes Containing Monoamine-Monoamide Dithiol As Potential Tumor Hypoxia Markers

Synthesis, Radiolabeling and in Vivo Biological Evaluation of 99Mtc-Labeled MAG3-based Bisnitroimidazole Complexes As Tumor Hypoxia Markers

Synthesis and preliminary biological evaluation of the 99mTc labeled nitrobenzoimidazole and nitrotriazole as tumor hypoxia markers.

<sup>99m</sup>Tc-Labeled Bombesin(7−14)NH<sub>2</sub>with Favorable Properties for SPECT Imaging of Colon Cancer

Comparative Biodistribution of Potential Anti-Glioblastoma Conjugates [111In]dtpa-Hegf and [111In]bz-Dtpa-hegf in Normal Mice

Tc-99m-Labeled Bombesin(7-14)Nh2 With Favorable Properties For Spect Imaging Of Colon Cancer

Kit formulation for preparation and biological evaluation of a novel 99m Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia

Radio-Labelling and Micro-Pet Study of Cu-64 Labelled Pnao-1-(2-Nitroimidazole) for Hypoxia Imaging

Hypoxic Imaging with 99Mtc-Hl91 Single Photon Emission Computed Tomography in Advanced Nonsmall Cell Lung Cancer

In Vitro and in Vivo Evaluation of a 64Cu-Labeled Propylene Amine Oxime Complex As a Potential Hypoxia Imaging Agent Bearing Two 3-Nitrotriazole Groups

Preparation and Biological Evaluation of 99Mtc-N4ipa for Single Photon Emission Computerized Tomography Imaging of Hypoxia in Mouse Tumor

Biodistribution and Pharmacokinetics of 99tcm Labeled Carbohydrated Peptides in Mice Bearing Tumors

Synthesis and Biodistribution of A New 99Mtc-Oxo Complex with Deoxyglucose Dithiocarbamate for Tumor Imaging

Preparation and Biodistribution of Tumor Hypoxia Imaging Agents With Different Charges

Synthesis and in Vitro Evaluation of Three (99M)tc-Labeled Hydroxamamide-Based Ligands As Markers for Hypoxic Cells

Biodistribution of 99 Tcm O-labeled MAG3-2-nitroimidazole hypoxia imaging agents with different spacers in S180 scarcoma-bearing mice